Trademark: 77165513
Word
BC-SERAPRO
Status
Dead
Status Code
602
Status Date
Thursday, March 26, 2009
Serial Number
77165513
Mark Type
3000
Filing Date
Wednesday, April 25, 2007
Published for Opposition
Tuesday, February 19, 2008
Abandoned Date
Monday, February 23, 2009

Trademark Owner History
Power3 Medical Products, Inc. - Owner At Publication

Classifications
5 Diagnostic reagents and diagnostic preparations for medical and veterinary purposes
Color is not claimed as a feature of the mark.
The mark consists of The literal element:" BC-SeraPro" in Arial Italic Font with an arch above the literal element off center to the left and an arch below the literal element off center to the right.

Trademark Events
Mar 26, 2009
Abandonment Notice Mailed - Failure To Respond
Mar 26, 2009
Abandonment - Failure To Respond Or Late Response
Aug 22, 2008
Non-Final Action Mailed
Aug 21, 2008
Su - Non-Final Action - Written
Aug 21, 2008
Amendment From Applicant Entered
Aug 21, 2008
Correspondence Received In Law Office
Aug 12, 2008
Paper Received
Jul 29, 2008
Non-Final Action Mailed
Jul 28, 2008
Su - Non-Final Action - Written
Jul 28, 2008
Statement Of Use Processing Complete
Jul 16, 2008
Use Amendment Filed
Jul 28, 2008
Case Assigned To Intent To Use Paralegal
Jul 16, 2008
Teas Statement Of Use Received
May 13, 2008
Noa Mailed - Sou Required From Applicant
Feb 19, 2008
Published For Opposition
Jan 30, 2008
Notice Of Publication
Jan 15, 2008
Law Office Publication Review Completed
Dec 5, 2007
Examiners Amendment Mailed
Dec 5, 2007
Approved For Pub - Principal Register
Dec 5, 2007
Examiner's Amendment Entered
Dec 5, 2007
Examiners Amendment -Written
Nov 30, 2007
Teas/Email Correspondence Entered
Nov 30, 2007
Correspondence Received In Law Office
Nov 20, 2007
Assigned To Lie
Oct 17, 2007
Teas Response To Office Action Received
Aug 14, 2007
Non-Final Action Mailed
Aug 14, 2007
Non-Final Action Written
Aug 8, 2007
Assigned To Examiner
May 1, 2007
Notice Of Design Search Code Mailed
Apr 30, 2007
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24